Browsing publications by Dr Alison Yarnall

Newcastle AuthorsTitleYearFull text
Dr Alison Yarnall
Dr Shirley Coleman
Professor David Burn
Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?2016
Dr Rachael Lawson
Dr Alison Yarnall
Dr Gordon Duncan
Dr Tien Kheng Khoo
Daniel Collerton
et al.
Cognitive decline and quality of life in incident Parkinson’s disease: the role of attention2016
Dr Gordon Duncan
Dr Michael Firbank
Dr Alison Yarnall
Dr Tien Kheng Khoo
Professor David Brooks
et al.
Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?2016
Dr Angela Pyle
Haidyan Anugrha
Dr Marzena Kurzawa-Akanbi
Dr Alison Yarnall
Professor David Burn
et al.
Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease2016
Dr Alison Yarnall
Dr Rachael Lawson
Dr Gordon Duncan
Dr Tien Kheng Khoo
Professor David Burn
et al.
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)2016
Dr Alison Yarnall
Dr Rachael Lawson
Dr Gordon Duncan
Dr Tien Kheng Khoo
Professor David Brooks
et al.
Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson's Disease?2015
Dr Michael Firbank
Dr Rachael Lawson
Dr Alison Yarnall
Dr Tien Kheng Khoo
Professor David Brooks
et al.
Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study2015
Dr Alison Yarnall
Professor David Deehan
Occurrence, management and outcomes of hip fractures in patients with Parkinson's disease2015
Dr Angela Pyle
Rebecca Brennan
Dr Marzena Kurzawa-Akanbi
Dr Alison Yarnall
Anais Thouin
et al.
Reduced CSF mitochondrial DNA is a biomarker for early-stage Parkinson's disease2015
Dr Emma Vardy
Dr Andrew Teodorczuk
Dr Alison Yarnall
Review of delirium in patients with Parkinson's disease2015
123456